Berberine Treat Metabolic Syndrome in Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
In early clinical study investigators confirmed that berberine could prevent glucose and lipid metabolism disorder in schizophrenia, so investigators intend to verify the effect and safety of berberine in treatment for metabolic syndrome in schizophrenia.
Epistemonikos ID: e9d4d62ea7b2e259f1186a811bfe63db795ae566
First added on: May 21, 2024